About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Phase III/Seroquel SR Bipolar Depression Monotherapy - US

Phase III/Seroquel SR Bipolar Depression Monotherapy - US

NCT00422214·54 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Provision of written informed consent
Documented diagnosis of Bipolar 1 disorder or Bipolar 11 disorder
Outpatient status at enrollment

You may not be if

Patients with \>8 mood episodes during the past 12 years
Use of prohibited medications
Substance or alcohol abuse or dependence
Current suicide risk or suicide attempt within last 6 months.

The record

StatusCompleted

PhasePhase 3

Taking part400

StartedDec 2006

UpdatedMar 25, 2009

Conditions

Affective Psychosis, Bipolar Depression, Bipolar Manic-Depressive Psychosis Psychoses, Manic-Depressive

Where54

Research Site
Birmingham, Alabama, United States
Research Site
Phoenix, Arizona, United States
Research Site
Scottsdale, Arizona, United States